Ozempic Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Semaglutide

Indications/Uses

Adjunct to diet & exercise in adults w/ insufficiently controlled type 2 DM as monotherapy when metformin is inappropriate due to intolerance or CIs; in addition to other medicinal products. Reduce risk of major adverse CV events composed of CV death, non-fatal MI & stroke in adults w/ type 2 diabetes who have established CV disease or are at high risk for CV disease.

Click to view Ozempic detailed prescribing information

Dosage/Direction for Use

SC Initially 0.25 mg once wkly, increased to 0.5 mg once wkly after 4 wk. May be further increased to 1 mg once wkly after at least 4 wk to improve glycaemic control.

Click to view Ozempic detailed prescribing information

Overdosage

View Ozempic overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Click to view Ozempic detailed prescribing information

Special Precautions

Not to be inj IV or IM. Not to be used in patients w/ type 1 DM or for diabetic ketoacidosis. Not an insulin substitute. Discontinue use if pancreatitis is suspected. Not recommended in patients w/ CHF NYHA class IV. Increased risk of hypoglycaemia in combination w/ insulin or sulfonylurea. GI effects; history of pancreatitis; diabetic retinopathy. May affect ability to drive & use machines. Not recommended in ESRD. Severe renal & hepatic impairment. Women of childbearing potential must use effective contraception. Not to be used during pregnancy & lactation. Childn & adolescents <18 yr. Elderly ≥75 yr.

Click to view Ozempic detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ozempic detailed prescribing information

Adverse Reactions

Hypoglycaemia; nausea, diarrhoea. Decreased appetite; dizziness; diabetic retinopathy complications; vomiting, abdominal pain & distension, constipation, dyspepsia, gastritis, GERD, eructation, flatulence; cholelithiasis; fatigue; increased lipase & amylase, decreased wt.

Click to view Ozempic detailed prescribing information

Drug Interactions

Frequent INR monitoring w/ warfarin or other coumarin derivatives. Caution w/ medicinal products requiring rapid GI absorption.

Click to view Ozempic detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Ozempic detailed prescribing information

Storage

View Ozempic storage conditions for details to ensure optimal shelf-life.

Description

View Ozempic description for details of the chemical structure and excipients (inactive components).

Action

View Ozempic mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BJ06 - semaglutide ; Belongs to the class of glucagon-like peptide-1 (GLP-1) analogues. Used in the treatment of diabetes.

Regulatory Classification

Patient Counseling Information

View Ozempic patient counselling information

Presentation/Packing

Form

Ozempic soln for inj (pre-filled pen) 1.34 mg/mL

Packing/Price

(2 mg/1.5 mL) 1's; (4 mg/3 mL) 1's

Ozempic

semaglutide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma